PAPER Pitz V, Malek N, Tobias ES, Grosset KA, Gentleman S, Grosset DG
SEARCH RESULTS
314 RESULTS
PAPER Grandjean JM, Jiu AY, West JW, Aoyagi A, Droege DG, Elepano M, Hirasawa M, Hirouchi M, Murakami R, Lee J, Sasaki K, Hirano S, Ohyama T, Tang BC, Vaz RJ, Inoue M, Olson SH, Prusiner SB, Conrad J, Paras NA
Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity.
ACS Med Chem Lett. 2020 Feb 13;11(2):127-132. Epub 2020 Jan 30 PubMed: 32071678PAPER Watanabe H, Tatsumi H, Kaide S, Shimizu Y, Iikuni S, Ono M
Structure-Activity Relationships of Radioiodinated 6,5,6-Tricyclic Compounds for the Development of Tau Imaging Probes.
ACS Med Chem Lett. 2020 Feb 13;11(2):120-126. Epub 2020 Jan 9 PubMed: 32071677PAPER Woo JA, Liu T, Fang CC, Castaño MA, Kee T, Yrigoin K, Yan Y, Cazzaro S, Matlack J, Wang X, Zhao X, Kang DE, Liggett SB
β-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregates.
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):5006-5015. Epub 2020 Feb 18 PubMed: 32071246PAPER Bi XA, Hu X, Wu H, Wang Y
Multimodal Data Analysis of Alzheimer's Disease Based on Clustering Evolutionary Random Forest.
IEEE J Biomed Health Inform. 2020 Feb 11;PP PubMed: 32071013PAPER Manoufali M, Mobashsher AT, Mohammed B, Bialkowski K, Mills PC, Abbosh A
Implantable Sensor for Detecting Changes in the Loss Tangent of Cerebrospinal Fluid.
IEEE Trans Biomed Circuits Syst. 2020 Jun;14(3):452-462. Epub 2020 Feb 12 PubMed: 32070996PAPER Mokarizadeh N, Karimi P, Erfani M, Sadigh-Eteghad S, Fathi Maroufi N, Rashtchizadeh N
β-Lapachone attenuates cognitive impairment and neuroinflammation in beta-amyloid induced mouse model of Alzheimer's disease.
Int Immunopharmacol. 2020 Apr;81:106300. Epub 2020 Feb 15 PubMed: 32070922PAPER Kosel F, Pelley JM, Franklin TB
Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology.
Neurosci Biobehav Rev. 2020 May;112:634-647. Epub 2020 Feb 15 PubMed: 32070692PAPER Carneiro P, Morais S, do Carmo Pereira M
Biosensors on the road to early diagnostic and surveillance of Alzheimer's disease.
Talanta. 2020 May 1;211:120700. Epub 2020 Jan 3 PubMed: 32070618PAPER Lowes H, Pyle A, Santibanez-Koref M, Hudson G
Circulating cell-free mitochondrial DNA levels in Parkinson's disease are influenced by treatment.
Mol Neurodegener. 2020 Feb 18;15(1):10. PubMed: 32070373PAPER Dutta N, Borah P, Mattaparthi VS
Effect of CTerm of human albumin on the aggregation propensity of Aβ1-42 peptide: a potential of mean force study.
J Biomol Struct Dyn. 2020 Mar 2;:1-9. PubMed: 32070240PAPER Montagne A, Nation DA, Zlokovic BV
APOE4 Accelerates Development of Dementia After Stroke: Is There a Role for Cerebrovascular Dysfunction?
Stroke. 2020 Mar;51(3):699-700. Epub 2020 Feb 18 PubMed: 32070225PAPER Pendlebury ST, Poole D, Burgess A, Duerden J, Rothwell PM, Oxford Vascular Study
APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.
Stroke. 2020 Mar;51(3):751-758. Epub 2020 Feb 18 PubMed: 32070224PAPER Li YT, Chang CY, Hsu YC, Fuh JL, Kuo WJ, Yeh JT, Lin FH
Impact of physiological noise in characterizing the functional MRI default-mode network in Alzheimer's disease.
J Cereb Blood Flow Metab. 2020 Feb 18;:271678X19897442. PubMed: 32070180PAPER Krishnan M, Hwang JS, Kim M, Kim YJ, Seo JH, Jung J, Ha E
β-hydroxybutyrate Impedes the Progression of Alzheimer's Disease and Atherosclerosis in ApoE-Deficient Mice.
Nutrients. 2020 Feb 13;12(2) PubMed: 32069870Current Filters
- Date Range : Feb 2020 to Feb 2020 x